Consistently, BIRC6 overexpression has been reported in several cancer types, including triple-negative breast cancer, prostate, renal, colorectal, childhood acute myeloid leukemia, ovarian, hepatocellular, esophageal squamous cell carcinoma, and non-small cell lung cancer (NSCLC) [28,29,30,31,32,33,34,35]. Here, BIRC6 is linked to non-small cell lung carcinoma.